Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications
Enabling faster analysis using advanced tools
31-Aug-2020
Technology Research
D9B1-01-00-00-00
HC03334-GL-TR_24701
Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans. Application of analytical tools help identify trends and patterns that may have been difficult to observe otherwise and provide results in the best possible way.
The Strategic Imperative 8™
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Data Science Industry
About The Growth Pipeline Engine™
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Key Findings
1.1 Clinical Trials Still the most Complex Step in the Lifecycle of Drug Development
1.2 Following Conventional Steps in Clinical Trials is an Ongoing Challenge
1.3 Importance of Data Science in Clinical Trials
1.4 Important Terminologies Associated with Data Science and its Role
2.1 Adoption of Data Science in Clinical Trials is Seen across the Globe
2.2 Key Factors to Leverage Use of Data Science in Clinical Trials
2.3 NLP and OCR are Extensively Used in Data Structuring
2.4 Data Science Taps Untapped Significant Information
2.5 Data science Tools Help Reduce Clinical Trial Timeline
2.6 Downstream Workflow of Data Science Tools
2.7 Medical Data Conversion to E health Data is an Essential Step
3.1 AI Based Models Provide Predictive Solutions
3.2 Data Driven Models’ Focus Areas
3.3 Key Challenges in Patient Enrollment
3.4 Use of Digital Platforms Increases Patient Retention
3.5 Role of Data Science in Leveraging Cancer Treatments
3.6 Role of Data Science in the Rare Disease Area
3.7 Enabling Virtual Clinical Trials Using Data Science during COVID-19
3.8 AI Tools Speed up Patient Recruitment
3.9 Data Sharing to be Driving Factor in AI Enabled Clinical Trials
4.1 Collaboration between Big Pharma and AI Companies to Leverage Clinical Trials
4.2 Tech Companies Come together to Pool Resources
4.3 Mendel.ai
4.4 Ai Cure
4.5 Inato
4.6 GNS Healthcare
4.7 Trials.ai
4.8 Antidote
4.9 Deep 6 Ai
4.10 BullFrog Ai
4.11 PathAI
4.12 Tempus
5.1 IP Overview of Data Science in Pharmaceutical Development
5.2 Top Patent List
5.3 Top Patents in Screening Patients Technology
5.4 Top Patents in Structured Platforms
6.1 Growth opportunity 1: Data Science driven Patient Selection
6.1 Growth Opportunity 1: Data Science-driven Patient Selection
6.2 Growth opportunity 2: FDA accelerated Data sharing has opened many opportunities
6.2 Growth Opportunity 2: FDA accelerated sharing has opened many opportunities (continued)
Abbreviation
Key Industry Contacts
YOUR NEXT STEPS
WHY FROST, WHY NOW?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.